Plasma Aβ Levels Do Not Reflect Brain Aβ Levels
Data up to Jan 2025
Total Citations Per Year
Abstract
References (29)
Clinical diagnosis of Alzheimer's disease
1984 • 27,279 citations
Neuropathological stageing of Alzheimer-related changes
1991 • 14,533 citations
Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
1996 • 2,543 citations
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)
1996 • 2,426 citations
Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED]
2001 • 2,072 citations
The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
1993 • 1,951 citations
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
1997 • 1,395 citations
Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease
2001 • 990 citations
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
1997 • 938 citations
Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy)
1994 • 806 citations
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.
1993 • 713 citations
Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration
2002 • 666 citations
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
2004 • 617 citations
Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease
2000 • 564 citations
Cerebrospinal fluid protein biomarkers for Alzheimer’s disease
2004 • 466 citations
Primary Progressive Aphasia — A Language-Based Dementia
2003 • 461 citations
Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study
2006 • 446 citations
Plasma Aβ40 and Aβ42 and Alzheimer’s disease
2003 • 425 citations
Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasma
2000 • 301 citations
Age but Not Diagnosis Is the Main Predictor of Plasma Amyloid β-Protein Levels
2003 • 258 citations
Amyloid β protein 1–40 and 1–42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease
2001 • 226 citations
Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
1996 • 183 citations
Innervation of Propatagial Musculature in a Flying Squirrel, <i>Glaucomys volans </i>(Rodentia, Sciuridae)
1996 • 162 citations
Amyloid β protein in plasma from patients with sporadic Alzheimer's disease
1996 • 156 citations
Elevated plasma amyloid β-peptide 1–42 and onset of dementia in adults with Down syndrome
2001 • 152 citations
The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta 42(43)
1997 • 111 citations
Plasma levels of amyloid β-protein 42 are increased in women with mild cognitive impairment
2004 • 105 citations
Preferential deposition of amyloid β protein (Aβ) in the form Aβ40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele
1997 • 92 citations
Primary cultures of neuronal and non-neuronal rat brain cells secrete similar proportions of amyloid β peptides ending at Aβ40 and Aβ42
1999 • 57 citations
Cited By (0)
No citing papers found in database